Citius Oncology Statistics Share Statistics Citius Oncology has n/a
shares outstanding. The number of shares has increased by 17.12%
in one year.
Shares Outstanding n/a Shares Change (YoY) 17.12% Shares Change (QoQ) 16.72% Owned by Institutions (%) n/a Shares Floating 4.5M Failed to Deliver (FTD) Shares 1,354 FTD / Avg. Volume 0.14%
Short Selling Information The latest short interest is 135.75K, so 0.16% of the outstanding
shares have been sold short.
Short Interest 135.75K Short % of Shares Out 0.16% Short % of Float 0.78% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -4.7 and the forward
PE ratio is -14.07.
Citius Oncology's PEG ratio is
-0.08.
PE Ratio -4.7 Forward PE -14.07 PS Ratio 0 Forward PS 2.5 PB Ratio 2.16 P/FCF Ratio -20.41 PEG Ratio -0.08
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Citius Oncology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.34,
with a Debt / Equity ratio of 0.08.
Current Ratio 0.34 Quick Ratio 0.08 Debt / Equity 0.08 Debt / EBITDA -0.18 Debt / FCF -0.78 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 576K Effective Tax Rate -2.8%
Stock Price Statistics The stock price has increased by 59.32% in the
last 52 weeks. The beta is 3.01, so Citius Oncology's
price volatility has been higher than the market average.
Beta 3.01 52-Week Price Change 59.32% 50-Day Moving Average 1.89 200-Day Moving Average 1.46 Relative Strength Index (RSI) 48.59 Average Volume (20 Days) 970,720
Income Statement
Revenue n/a Gross Profit n/a Operating Income -20.57M Net Income -21.15M EBITDA -20.57M EBIT -20.57M Earnings Per Share (EPS) -0.3
Full Income Statement Balance Sheet The company has 112 in cash and 3.8M in
debt, giving a net cash position of -3.8M.
Cash & Cash Equivalents 112 Total Debt 3.8M Net Cash -3.8M Retained Earnings -39.28M Total Assets 91.71M Working Capital -34.68M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 126.35K
and capital expenditures -5M, giving a free cash flow of -4.87M.
Operating Cash Flow 126.35K Capital Expenditures -5M Free Cash Flow -4.87M FCF Per Share -0.07
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
